ASPS Altisource beats Q1 EPS estimates by 35 yet shares slide 2 on cautious revenue outlook The quiet strength in Charles SCHW business model Nudges Down 20260508 Amgen Inc AMGN Sustained Biotech Sector Outperformance Backed by MoatLike Competitive Advantages Construction Partners ROAD Stock Is It Forming a Reversal Q1 2026 EPS Beats Forecasts